CLEAR CELL RENAL CELL CARCINOMA
Clinical trials for CLEAR CELL RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new CLEAR CELL RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for CLEAR CELL RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Drug combo paves way for Kidney-Saving surgery in tough cancer cases
Disease control CompletedThis study tested whether giving a combination of two drugs (cadonilimab and lenvatinib) before surgery could help patients with high-risk kidney cancer successfully undergo a kidney-sparing operation. The goal was to shrink tumors enough to make a complex, kidney-preserving surg…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Apr 04, 2026 02:20 UTC
-
New cancer drug targets immune system in first human test
Disease control CompletedThis early-stage study tested the safety and initial effectiveness of a new drug called CHS-388 in adults with advanced solid tumors that had stopped responding to standard treatments. The drug, an antibody designed to target a specific immune system protein (IL-27), was tested b…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Coherus Oncology, Inc. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New drug tested for Tough-to-Treat kidney cancer
Disease control CompletedThis early-stage study tested a new drug called ARO-HIF2 in 26 patients with advanced kidney cancer that had stopped responding to standard treatments. The main goals were to find a safe dose and see how the body processes the drug. Researchers also looked for early signs that th…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
CRISPR-Edited immune cells battle tough cancers in new trial
Disease control CompletedThis study tested a new type of cell therapy called CTX131 for adults with advanced solid tumors that have returned or stopped responding to standard treatments. CTX131 uses a patient's own immune cells that are genetically modified in a lab to better target and fight cancer cell…
Matched conditions: CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC